Encompass health corporation announces amendments to consent solicitation of holders of its 4.500% senior notes due 2028, 4.750% senior notes due 2030 and 4.625% senior notes due 2031

Birmingham, ala., jan. 18, 2022 /prnewswire/ -- encompass health corporation ("encompass health" or the "company") (nyse: ehc), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, today announced that it is amending and supplementing its previously announced solicitation of consents (the "consent solicitation") from the holders of its 4.500% senior notes due 2028 (the "2028 notes"), 4.750% senior notes due 2030 (the "2030 notes") and 4.625% senior notes due 2031 (the "2031 notes" and together with the 2028 notes and the 2030 notes, the "notes") to certain proposed amendments (the "proposed amendments") described in the consent solicitation statement, dated december 9, 2021 (as previously amended on december 16, 2021 and january 12, 2022, as amended hereby and as may be further amended or supplemented from time to time, the "statement") to the indenture governing the notes (the "indenture").
EHC Ratings Summary
EHC Quant Ranking